Skip to main content
. 2015 Mar 30;6(16):14374–14384. doi: 10.18632/oncotarget.3720

Figure 4. Expression of CD22 in patients with MF.

Figure 4

Figure 4

A. RT-PCR analysis of CD22 expression in CTCL lesional skin from patients. B. Double-staining with anti-CD4 (PE) and anti-CD22 (FITC) of biopsies from tumor stage of two MF patients.